{"id":5699,"date":"2024-04-29T10:13:35","date_gmt":"2024-04-29T15:13:35","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5699"},"modified":"2025-06-27T11:19:04","modified_gmt":"2025-06-27T16:19:04","slug":"nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u304cOIS\u304a\u3088\u3073\u7db2\u819c\u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30b5\u30df\u30c3\u30c8\u3067\u767a\u8868"},"content":{"rendered":"
\n
\n
\n

<\/h1>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n

\u30c0\u30e9\u30b9<\/span><\/span>, 2024\u5e744\u670829\u65e5<\/span><\/span>\u00a0 \u2014 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u7db2\u819c\u5909\u6027\u75be\u60a3\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u5f8c\u671f\u81e8\u5e8a\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u306f\u3001\u672c\u65e5\u3001 \u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3<\/span>\u3001PhD\u3001\u5171\u540c\u5275\u8a2d\u8005\u3001\u793e\u9577\u304c\u3001 \u7db2\u819c\u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30b5\u30df\u30c3\u30c8 2024<\/a> \u305d\u3057\u3066\u305d\u306e \u773c\u79d1\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30bd\u30fc\u30b9\uff08OIS\uff09\u7db2\u819c\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30b5\u30df\u30c3\u30c8<\/a>\u3069\u3061\u3089\u3082\u30b7\u30a2\u30c8\u30eb\u3067\u958b\u50ac\u3055\u308c\u307e\u3059\u3002 \u30ef\u30b7\u30f3\u30c8\u30f3<\/span>\u3053\u308c\u3089\u306e\u30a4\u30d9\u30f3\u30c8\u306b\u306f\u7d4c\u55b6\u9663\u3082\u51fa\u5e2d\u3057\u307e\u3059\u3002\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u8a73\u7d30\u306f\u6b21\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n

\u5931\u660e\u64b2\u6ec5\u8ca1\u56e3 \u7db2\u819c\u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30b5\u30df\u30c3\u30c8 2024<\/a>
\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb: <\/b>\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u9032\u6b69\u306b\u5411\u3051\u305f\u898f\u5236\u4e0a\u306e\u8ab2\u984c\u3092\u4e57\u308a\u8d8a\u3048\u308b
\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:\u00a0<\/b>\u81e8\u5e8a\u8a66\u9a13\u306e\u8a2d\u8a08\uff1a\u898f\u5236
\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:<\/b>\u00a02024\u5e745\u67083\u65e5
\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:<\/b>\u00a04:55 \u2013 \u5348\u5f8c5\u664210\u5206\uff08\u592a\u5e73\u6d0b\u6a19\u6e96\u6642\uff09<\/span>
\u4f4d\u7f6e\uff1a<\/b>\u00a0\u30cf\u30a4\u30a2\u30c3\u30c8 \u30ea\u30fc\u30b8\u30a7\u30f3\u30b7\u30fc \u30b7\u30a2\u30c8\u30eb
\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc<\/b>: \u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u3001\u5171\u540c\u5275\u8a2d\u8005\u517c\u793e\u9577<\/p>\n

\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u3001\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3067\u3001\u7db2\u819c\u75be\u60a3\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u9032\u6b69\u3055\u305b\u308b\u305f\u3081\u306e\u88fd\u9020\u3068\u81e8\u5e8a\u898f\u5236\u306e\u8ab2\u984c\u306b\u3064\u3044\u3066\u7d39\u4ecb\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u898f\u5236\u5f53\u5c40\u3068\u5354\u529b\u3057\u3066\u907a\u4f1d\u5b50\u6cbb\u7642\u88fd\u54c1\u306e\u52b9\u529b\u3068\u81e8\u5e8a\u8a66\u9a13\u306e\u6709\u52b9\u6027\u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8\u3092\u6e2c\u5b9a\u3059\u308b\u305f\u3081\u306e\u30a2\u30c3\u30bb\u30a4\u306e\u8a2d\u8a08\u3068\u958b\u767a\u306b\u643a\u308f\u3063\u305f\u7d4c\u9a13\u304b\u3089\u5b66\u3093\u3060\u6559\u8a13\u3092\u5171\u6709\u3057\u307e\u3059\u3002<\/p>\n

\u773c\u79d1\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30bd\u30fc\u30b9\uff08OIS\uff09\u7db2\u819c\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30b5\u30df\u30c3\u30c8<\/a>
\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb: <\/b>\u7db2\u819c\u5909\u6027\u75c7\u60a3\u8005\u306b\u304a\u3051\u308b\u5909\u7570\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9
\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:\u00a0<\/b>\u518d\u751f\u533b\u7642\u306b\u6ce8\u76ee
\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:<\/b>\u00a02024\u5e745\u67084\u65e5
\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:<\/b> 3:00 \u2013 \u5348\u5f8c4\u66425\u5206\uff08\u592a\u5e73\u6d0b\u6a19\u6e96\u6642\uff09<\/span>
\u4f4d\u7f6e\uff1a<\/b>\u00a0\u30d5\u30a9\u30fc\u30b7\u30fc\u30ba\u30f3\u30ba \u30db\u30c6\u30eb \u30b7\u30a2\u30c8\u30eb
\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc<\/b>: \u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u3001\u5171\u540c\u5275\u8a2d\u8005\u517c\u793e\u9577<\/p>\n

\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u306b\u5bfe\u3059\u308b\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u306e\u7121\u4f5c\u70ba\u5316\u81e8\u5e8a\u8a66\u9a13\u306e\u826f\u597d\u306a\u8a66\u9a13\u7d42\u4e86\u6642\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u30c7\u30fc\u30bf\u3092\u53d7\u3051\u3066\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u4eca\u5f8c\u306e\u6d3b\u52d5\u306b\u95a2\u3059\u308b\u4f01\u696d\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u305d\u306e\u5f8c\u3001\u773c\u79d1\u5b66\u6559\u6388\u3067\u5171\u540c\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u306e\u30de\u30fc\u30af\u30fbS\u30fb\u30d5\u30de\u30e6\u30f3\u533b\u5e2b\uff08\u533b\u5b66\u535a\u58eb\uff09\u304c\u53f8\u4f1a\u3092\u52d9\u3081\u308b\u518d\u751f\u533b\u7642\u306b\u95a2\u3059\u308b\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u304c\u884c\u308f\u308c\u307e\u3059\u3002\u5357\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5927\u5b66<\/span> \u30ed\u30b9\u30ad\u773c\u79d1\u7814\u7a76\u6240\u3002<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066
<\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30c3\u30af\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u3002\u540c\u793e\u306e\u4e3b\u529b\u88fd\u54c1\u3067\u3042\u308bMCO-010\u306f\u3001 \u6700\u8fd1\u767a\u8868\u3055\u308c\u305f100\u9031\u9593\u306e\u30c7\u30fc\u30bf\u306f<\/a> \u5fa9\u5143\u30d5\u30a7\u30fc\u30ba 2b<\/span>\u540c\u793e\u306f\u7c73\u56fd\u3067RP\u306b\u5bfe\u3059\u308b\u7b2c3\u76f8\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u4e8c\u91cd\u76f2\u691c\u6a21\u64ec\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\uff08NCT04945772\uff09\u3092\u5b9f\u65bd\u3057\u305f\u3002\u540c\u793e\u306f\u307e\u305f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u306b\u5bfe\u3059\u308bMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3082\u6700\u8fd1\u5b8c\u4e86\u3057\u305f\uff08NCT05417126\uff09\u3002MCO-010\u306f\u3001RP\u3068\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u306e\u4e21\u65b9\u306b\u5bfe\u3057\u3066FDA\u306e\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068FDA\u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u308b\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u306b\u4f34\u3046\u5730\u56f3\u72b6\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054MCO-020\u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u308b\u3002<\/p>\n

\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b>
\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba
212-600-1902
PR@nanostherapeutics.com<\/a><\/p>\n

\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"

DALLAS, April 29, 2024\u00a0 \u2014 Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today announced that Samarendra Mohanty, PhD, Co-Founder, and President, will present in the Retinal Cell and Gene Therapy Innovation Summit 2024 and the Ophthalmology Innovation Source\u00a0(OIS) Retina Innovation Summit, both taking place in\u00a0Seattle, Washington. The management team will be present at these events. Details for the presentations are as follows: Foundation Fighting Blindness Retinal Cell and Gene Therapy Innovation Summit 2024Presentation Title: Navigating the regulatory challenges for advancing gene therapiesSession Title:\u00a0Clinical Trial Design: RegulatorySession Date:\u00a0May 3, 2024Session Time:\u00a04:55 \u2013 5:10 p.m. PTLocation:\u00a0Hyatt Regency SeattlePresenter: Samarendra Mohanty, PhD, Co-Founder and President […]<\/p>\n","protected":false},"author":6,"featured_media":5703,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5699","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics to Present at the OIS and Retinal Cell and Gene Therapy Innovation Summits - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics to Present at the OIS and Retinal Cell and Gene Therapy Innovation Summits - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-29T15:13:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T16:19:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_OIS-FFB_2024_REV3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_OIS-FFB_2024_REV3.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/29\\\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/29\\\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics to Present at the OIS and Retinal Cell and Gene Therapy Innovation Summits\",\"datePublished\":\"2024-04-29T15:13:35+00:00\",\"dateModified\":\"2025-06-27T16:19:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/29\\\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\\\/\"},\"wordCount\":397,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/29\\\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/NSCOPE_LI_OIS-FFB_2024_REV3.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/29\\\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/29\\\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\\\/\",\"name\":\"Nanoscope Therapeutics to Present at the OIS and Retinal Cell and Gene Therapy Innovation Summits - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/29\\\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/29\\\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/NSCOPE_LI_OIS-FFB_2024_REV3.jpg\",\"datePublished\":\"2024-04-29T15:13:35+00:00\",\"dateModified\":\"2025-06-27T16:19:04+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/29\\\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/29\\\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/29\\\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/NSCOPE_LI_OIS-FFB_2024_REV3.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/NSCOPE_LI_OIS-FFB_2024_REV3.jpg\",\"width\":1200,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/29\\\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics to Present at the OIS and Retinal Cell and Gene Therapy Innovation Summits\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001OIS\u304a\u3088\u3073\u7db2\u819c\u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30b5\u30df\u30c3\u30c8\u3067\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u5b9f\u65bd - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics to Present at the OIS and Retinal Cell and Gene Therapy Innovation Summits - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2024-04-29T15:13:35+00:00","article_modified_time":"2025-06-27T16:19:04+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_OIS-FFB_2024_REV3.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_OIS-FFB_2024_REV3.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics to Present at the OIS and Retinal Cell and Gene Therapy Innovation Summits","datePublished":"2024-04-29T15:13:35+00:00","dateModified":"2025-06-27T16:19:04+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/"},"wordCount":397,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_OIS-FFB_2024_REV3.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/","url":"https:\/\/nanostherapeutics.com\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001OIS\u304a\u3088\u3073\u7db2\u819c\u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30b5\u30df\u30c3\u30c8\u3067\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u5b9f\u65bd - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_OIS-FFB_2024_REV3.jpg","datePublished":"2024-04-29T15:13:35+00:00","dateModified":"2025-06-27T16:19:04+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_OIS-FFB_2024_REV3.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_OIS-FFB_2024_REV3.jpg","width":1200,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2024\/04\/29\/nanoscope-therapeutics-to-present-at-the-ois-and-retinal-cell-and-gene-therapy-innovation-summits\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics to Present at the OIS and Retinal Cell and Gene Therapy Innovation Summits"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5699"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5699\/revisions"}],"predecessor-version":[{"id":9048,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5699\/revisions\/9048"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5703"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}